Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAXITAMAB-GQGK Cause Hypersensitivity? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hypersensitivity have been filed in association with NAXITAMAB-GQGK. This represents 5.3% of all adverse event reports for NAXITAMAB-GQGK.

8
Reports of Hypersensitivity with NAXITAMAB-GQGK
5.3%
of all NAXITAMAB-GQGK reports
0
Deaths
1
Hospitalizations

How Dangerous Is Hypersensitivity From NAXITAMAB-GQGK?

Of the 8 reports, 1 (12.5%) required hospitalization, and 3 (37.5%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAXITAMAB-GQGK. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does NAXITAMAB-GQGK Cause?

Hypotension (58) Pain (53) Hypertension (29) Rash (24) Urticaria (21) Oxygen saturation decreased (17) Bronchospasm (14) Off label use (14) Hypoxia (13) Tachycardia (13)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which NAXITAMAB-GQGK Alternatives Have Lower Hypersensitivity Risk?

NAXITAMAB-GQGK vs NEBIVOLOL NAXITAMAB-GQGK vs NECITUMUMAB NAXITAMAB-GQGK vs NEDAPLATIN NAXITAMAB-GQGK vs NEFAZODONE NAXITAMAB-GQGK vs NEFOPAM

Related Pages

NAXITAMAB-GQGK Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity NAXITAMAB-GQGK Demographics